OneMedNet Corp (ONMD) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 15, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ONMD SEC filings page.
OneMedNet Corp (ONMD) reported $1.5M in revenue over the twelve months to Jun 30, 2026, up 216.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue recovered in FY2025, but OneMedNet's development-stage cost base still converted growth into deeper operating cash consumption.
The improvement in net loss from$10.1M to$2.8M did not reflect healthier operations: operating loss remained near$9.6M while operating cash outflow widened from$7.0M to$7.5M . That gap indicates the reported bottom-line improvement came from items below operating performance rather than from the core cost structure.
Development spending remains large relative to the business: FY2025 R&D was
External financing remains central to liquidity: the FY2025 current ratio was 0.4x, financing supplied
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of OneMedNet Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
OneMedNet Corp's reported operating margin for fiscal year 2025 is below the lowest share of revenue this page publishes, so the figure is not shown here. This dimension scores 19/100.
OneMedNet Corp's revenue surged 111.4% year-over-year to $1.4M, reflecting rapid business expansion. This strong growth earns a score of 76/100.
Not available for OneMedNet Corp, and counted as zero in the overall score.
OneMedNet Corp's current ratio of 0.43 is below the typical benchmark, resulting in a score of 3/100. This tight liquidity could limit financial flexibility if cash inflows slow.
OneMedNet Corp's reported free cash flow margin for fiscal year 2025 is below the lowest share of revenue this page publishes, so the figure is not shown here. This dimension scores 1/100.
Not available for OneMedNet Corp, and counted as zero in the overall score.
OneMedNet Corp scores -80.41, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($27.7M) relative to total liabilities ($5.1M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
OneMedNet Corp passes 5 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
OneMedNet Corp reported a net loss of $2.8M while operations used $7.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.
OneMedNet Corp reported an operating loss of $9.7M against $67K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
OneMedNet Corp generated $292K in revenue in Q2 2026. This represents an increase of 88.4% from the same quarter a year earlier. Against the prior quarter it is up 204.2%.
OneMedNet Corp reported -$2.2M in net income in Q2 2026. This represents a decrease of 172.8% from the same quarter a year earlier. Against the prior quarter it is up 11.5%.
OneMedNet Corp earned -$0.04 per diluted share (EPS) in Q2 2026. This represents a decrease of 157.1% from the same quarter a year earlier. It is unchanged from the prior quarter.
Not reported for Q2 2026.
Cash & Balance Sheet
OneMedNet Corp recorded an outflow of $1.9M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 14.1% from the same quarter a year earlier. Against the prior quarter it is down 22.0%.
OneMedNet Corp held $358K in cash against $132K in long-term debt as of Q2 2026, with $4.7M of liabilities due within a year.
Not reported for Q2 2026.
Margins & Returns
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for Q2 2026.
Capital Allocation
OneMedNet Corp invested $324K in research and development in Q2 2026. This represents a decrease of 15.2% from the same quarter a year earlier. Against the prior quarter it is up 4.2%.
OneMedNet Corp invested $9K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 200.0% from the same quarter a year earlier. Against the prior quarter it is up 350.0%.
Not reported for Q2 2026.
ONMD Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-K | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-K | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $292K+88.4% | $96K-29.9% | $890K+3323.1% | $177K+24.6% | $155K-31.7% | $137K-44.8% | $26K-91.9% | $142K-56.4% |
| Cost of Revenue | $857K+116.4% | $476K+31.9% | $706K+1257.7% | $399K+76.5% | $396K+20.4% | $361K+13.9% | $52K-84.6% | $226K-22.9% |
| Gross Profit | -$565K-134.4% | -$380K-69.6% | $184K+807.7% | -$222K-164.3% | -$241K-136.3% | -$224K-224.6% | -$26K-62.5% | -$84K-354.5% |
| R&D Expenses | $324K-15.2% | $311K-10.6% | $462K+35.5% | $323K+8.4% | $382K-0.3% | $348K-21.8% | $341K-31.7% | $298K-26.4% |
| SG&A Expenses | $981K-17.1% | $1.5M+8.9% | $2.4M+14.4% | $1.4M-23.6% | $1.2M-31.1% | $1.4M+0.3% | $2.1M+100.1% | $1.8M+38.3% |
| Operating Income | -$2.3M-9.6% | -$2.6M-14.7% | -$3.1M-15.9% | -$2.2M+4.3% | -$2.1M+15.9% | -$2.2M-5.9% | -$2.7M | -$2.3M-21.2% |
| EBITDA | N/A | -$2.5M-14.9% | N/A | N/A | N/A | -$2.2M-5.8% | -$2.7M | -$2.3M-21.3% |
| Interest Expense | $9K-59.1% | $10K-67.7% | $8K-91.4% | $6K-57.1% | $22K+46.7% | $31K+24.0% | $93K | $14K |
| Net Income | -$2.2M-172.8% | -$2.5M-29.0% | -$3.1M-32.3% | -$741K+64.0% | $3.0M+183.1% | -$1.9M+9.8% | -$2.4M | -$2.1M+85.1% |
| EPS (Basic) | -$0.04-157.1% | -$0.04+33.3% | -$0.070.0% | -$0.01+85.7% | $0.07+150.0% | -$0.06+25.0% | -$0.07-103.6% | -$0.07+97.8% |
| EPS (Diluted) | -$0.04-157.1% | -$0.04 | -$0.070.0% | -$0.01 | $0.07 | -$0.06+25.0% | -$0.07-103.6% | -$0.07 |
| Diluted Shares (Avg) | 58M+51.1% | 55M | N/A | 53M | 38M | 34M+36.8% | N/A | 29M |
Not reported in any period shown, so not listed: Income Tax.
ONMD Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-K | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-K | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.4M-41.6% | $1.5M-13.0% | $2.2M-42.3% | $1.5M-65.7% | $2.3M+124.5% | $1.7M+130.9% | $3.7M+703.2% | $4.4M+52.8% |
| Current Assets | $1.3M-42.1% | $1.5M-10.5% | $2.1M-42.1% | $1.4M-66.4% | $2.3M+137.1% | $1.6M+148.6% | $3.6M+891.5% | $4.3M+435.3% |
| Cash & Equivalents | $358K+193.4% | $233K+61.8% | $585K+240.1% | $149K-92.3% | $122K-70.0% | $144K-17.2% | $172K+266.0% | $1.9M+216.0% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $664K+161.4% | $697K+182.2% | $495K+132.4% | $582K+823.8% | $254K+238.7% | $247K-2.4% | $213K+40.1% | $63K-40.0% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $4.9M-21.0% | $5.6M-69.4% | $5.1M-74.0% | $5.4M-70.8% | $6.2M-69.5% | $18.3M+11.1% | $19.7M+41.5% | $18.7M-63.1% |
| Current Liabilities | $4.7M-23.3% | $5.4M-70.5% | $4.8M-74.9% | $5.0M-73.1% | $6.2M-69.3% | $18.2M+23.9% | $19.2M+39.0% | $18.6M-62.7% |
| Non-Current Liabilities | $156K+766.7% | $231K+80.5% | $291K-35.2% | $440K+1471.4% | $18K-90.1% | $128K-92.9% | $449K+560.3% | $28K-96.3% |
| Long-Term Debt | $132K | $176K-92.5% | $220K-90.5% | N/A | N/A | $2.3M | $2.3M+398.7% | $2.3M |
| Total Equity | -$3.5M+8.4% | -$4.1M+75.4% | -$3.0M+81.4% | -$3.9M+72.4% | -$3.8M+80.0% | -$16.6M-5.4% | -$15.9M-18.7% | -$14.3M+70.1% |
| Retained Earnings | -$109.0M-8.5% | -$106.8M-3.2% | -$104.4M-2.8% | -$101.2M-2.1% | -$100.5M-3.4% | -$103.5M-10.6% | -$101.6M-11.1% | -$99.2M-11.6% |
Not reported in any period shown, so not listed: Inventory, Goodwill.
ONMD Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-K | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-K | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.9M+14.3% | -$1.5M+16.8% | -$1.7M+14.2% | -$1.7M+8.2% | -$2.2M-45.4% | -$1.9M-19.8% | -$2.0M-15.7% | -$1.9M-73.0% |
| Depreciation & Amortization | N/A | $11K-8.3% | $9K-65.4% | N/A | N/A | $12K+9.1% | $26K+188.9% | $10K0.0% |
| Stock-Based Compensation | N/A | $431K+107.2% | N/A | $142K-31.4% | $197K+91.3% | $208K+51.8% | N/A | $207K-74.1% |
| Capital Expenditures | $9K+200.0% | $2K-60.0% | $5K-85.7% | $0-100.0% | $3K+200.0% | $5K-16.7% | $35K+118.8% | $9K-57.1% |
| Free Cash Flow | -$1.9M+14.1% | -$1.5M+16.9% | -$1.7M+15.4% | -$1.7M+8.6% | -$2.2M-45.5% | -$1.9M-19.7% | -$2.0M-16.7% | -$1.9M-70.6% |
| Investing Cash Flow | $56K+108.4% | $352K-81.7% | -$51K-114.0% | $1.1M+147.4% | -$670K-66900.0% | $1.9M+32100.0% | $365K+2381.3% | -$2.3M-11042.9% |
| Financing Cash Flow | $1.9M-31.5% | $838K+991.5% | $2.2M+1779.4% | $666K-87.8% | $2.8M+39.1% | -$94K-105.6% | -$131K-111.1% | $5.5M+284.9% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
ONMD Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-K | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-K | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -193.5% | -395.8% | 20.7%+120.7pp | -125.4% | -155.5% | -163.5% | -100.0%-95.0pp | -59.2%-69.3pp |
| Operating Margin | -774.3% | -2658.3% | -353.4% | -1262.7% | -1331.0% | -1623.4% | -10438.5% | -1645.1% |
| Net Margin | -743.8% | -2555.2% | -352.8% | -418.6% | 1923.9% | -1388.3% | -9126.9% | -1449.3% |
| Return on Assets | -159.2%-286.8pp | -162.8%-52.9pp | -146.0%-82.3pp | -49.2%-2.3pp | 127.6%+472.4pp | -109.8%+171.4pp | -63.7% | -46.9%+435.2pp |
| Current Ratio | 0.28-0.1x | 0.27+0.2x | 0.43+0.2x | 0.29+0.1x | 0.37+0.3x | 0.090.0x | 0.19+0.2x | 0.23+0.2x |
| Asset Turnover | 0.21+0.1x | 0.060.0x | 0.41+0.4x | 0.12+0.1x | 0.07-0.2x | 0.08-0.3x | 0.01-0.7x | 0.03-0.1x |
| FCF Margin | -645.2% | -1608.3% | -193.0% | -987.0% | -1414.2% | -1356.9% | -7811.5% | -1346.5% |
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.
Note: Shareholder equity is negative (-$3.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.43), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| OneMedNet Corp ONMD | FY2025 | $1.4M | -$2.8M | N/A | $27.7M | 17/100 |
| Heartbeam, Inc. BEAT | FY2025 | N/A | -$21.0M | N/A | $22.1M | — |
| Zhongchao Inc. ZCMD | FY2025 | $11.4M | -$6.3M | -55.5% | $6.1M | 33/100 |
| Mangoceuticals, Inc. MGRX | FY2025 | $456K | -$20.6M | N/A | $7.3M | — |
| Healthcare Triangle, Inc. HCTI | FY2025 | $13.9M | -$9.5M | -68.2% | $5.6M | 30/100 |
Where OneMedNet Corp Ranks
Frequently Asked Questions
What is OneMedNet Corp's annual revenue?
OneMedNet Corp (ONMD) reported $1.4M in total revenue for fiscal year 2025. This represents a 111.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is OneMedNet Corp's revenue growing?
OneMedNet Corp (ONMD) revenue grew by 111.4% year-over-year, from $643K to $1.4M in fiscal year 2025.
Is OneMedNet Corp profitable?
No, OneMedNet Corp (ONMD) reported a net income of -$2.8M in fiscal year 2025.
What is OneMedNet Corp's EBITDA?
OneMedNet Corp (ONMD) had EBITDA of -$9.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does OneMedNet Corp have?
As of fiscal year 2025, OneMedNet Corp (ONMD) had $585K in cash and equivalents against $220K in long-term debt.
What is OneMedNet Corp's gross margin?
OneMedNet Corp (ONMD) had a gross margin of -37.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is OneMedNet Corp's free cash flow?
OneMedNet Corp (ONMD) recorded an outflow of $7.5M in free cash flow during fiscal year 2025. This represents a -7.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is OneMedNet Corp's operating cash flow?
OneMedNet Corp (ONMD) recorded an outflow of $7.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are OneMedNet Corp's total assets?
OneMedNet Corp (ONMD) had $2.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are OneMedNet Corp's capital expenditures?
OneMedNet Corp (ONMD) invested $13K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does OneMedNet Corp spend on research and development?
OneMedNet Corp (ONMD) invested $1.5M in research and development during fiscal year 2025.
What is OneMedNet Corp's current ratio?
OneMedNet Corp (ONMD) had a current ratio of 0.43 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is OneMedNet Corp's return on assets (ROA)?
OneMedNet Corp (ONMD) had a return on assets of -130.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is OneMedNet Corp's P/E ratio?
OneMedNet Corp (ONMD) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $27.7M as of Oct 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is OneMedNet Corp's price-to-sales ratio?
OneMedNet Corp (ONMD) trades at 19.0x sales, its market capitalization divided by revenue of $1.5M revenue, trailing 12 months to June 30, 2026. The market capitalization is $27.7M as of Oct 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does OneMedNet Corp's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, OneMedNet Corp (ONMD) held $585K in cash, cash equivalents and investments, and reported an operating cash outflow of $7.5M over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is OneMedNet Corp's debt-to-equity ratio negative or not reported?
OneMedNet Corp (ONMD) has negative shareholder equity of -$3.0M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is OneMedNet Corp's Altman Z-Score?
OneMedNet Corp (ONMD) has an Altman Z-Score of -80.41, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is OneMedNet Corp's Piotroski F-Score?
OneMedNet Corp (ONMD) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are OneMedNet Corp's earnings high quality?
OneMedNet Corp (ONMD) reported a net loss of $2.8M while operations used $7.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can OneMedNet Corp cover its interest payments?
OneMedNet Corp (ONMD) reported an operating loss of $9.7M against $67K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is OneMedNet Corp?
OneMedNet Corp (ONMD) scores 17 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.